The Japan Home vs. Office blood pressure Measurement Evaluation with AI Multi-center randomized controlled study on efficacy of PREMINENT (losartan 50 mg/HCTZ 12.5 mg) and high-dose Angiotensin Receptor Blockers (ARBs) on home blood pressure / clinic blood pressure / augmentation index / central blood pressure in patients with uncontrolled hypertension under moderate-dose ARB monotherapy

Trial Profile

The Japan Home vs. Office blood pressure Measurement Evaluation with AI Multi-center randomized controlled study on efficacy of PREMINENT (losartan 50 mg/HCTZ 12.5 mg) and high-dose Angiotensin Receptor Blockers (ARBs) on home blood pressure / clinic blood pressure / augmentation index / central blood pressure in patients with uncontrolled hypertension under moderate-dose ARB monotherapy

Completed
Phase of Trial: Phase IV

Latest Information Update: 12 May 2016

At a glance

  • Drugs Losartan/hydrochlorothiazide (Primary) ; Angiotensin receptor antagonists; Candesartan cilexetil; Losartan; Olmesartan medoxomil; Telmisartan; Valsartan
  • Indications Essential hypertension
  • Focus Therapeutic Use
  • Most Recent Events

    • 30 Sep 2010 Results reported at the 23rd Scientific Meeting of the International Society of Hypertension.
    • 07 Jan 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top